Unknown

Dataset Information

0

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma.

ABSTRACT: Despite the advances in screening protocols and treatment options, hepatocellular carcinoma (HCC) is still considered to be the most lethal malignancy in patients with liver cirrhosis. Moreover, the survival outcomes after failure of first-line therapy for unresectable HCC is still poor with limited therapeutic options. One of these options is immune checkpoint inhibitors. The aim of this study is to comprehensively review the efficacy and safety of immune checkpoint inhibitors for patients with HCC.

SUBMITTER: Abd El Aziz MA 

PROVIDER: S-EPMC7712941 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma.

Abd El Aziz Mohamed A MA   Facciorusso Antonio A   Nayfeh Tarek T   Saadi Samer S   Elnaggar Mohamed M   Cotsoglou Christian C   Sacco Rodolfo R  

Vaccines 20201019 4

Despite the advances in screening protocols and treatment options, hepatocellular carcinoma (HCC) is still considered to be the most lethal malignancy in patients with liver cirrhosis. Moreover, the survival outcomes after failure of first-line therapy for unresectable HCC is still poor with limited therapeutic options. One of these options is immune checkpoint inhibitors. The aim of this study is to comprehensively review the efficacy and safety of immune checkpoint inhibitors for patients with  ...[more]

Similar Datasets

Unknown Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-analysis.
| S-EPMC8649834 | biostudies-literature
Unknown Immune checkpoint inhibitors for hepatocellular carcinoma.
| S-EPMC6095178 | biostudies-literature
Unknown Immune checkpoint inhibitors for hepatocellular carcinoma.
| S-EPMC7944520 | biostudies-literature
Unknown Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview.
| S-EPMC7821931 | biostudies-literature
Unknown Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment.
| S-EPMC8150670 | biostudies-literature
Unknown Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma.
| S-EPMC7017111 | biostudies-literature
Unknown Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges.
| S-EPMC6394775 | biostudies-literature
Unknown Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma.
| S-EPMC7678689 | biostudies-literature
Unknown Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
| S-EPMC8234948 | biostudies-literature
Unknown Emerging role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
| S-EPMC6843273 | biostudies-literature